DocGo Inc. - Common Stock DCGO 深 滬
已收盤 08-01 16:00:00 美东时间
1.33
-0.030
-2.21%
華盛通- 最 高1.38
- 今 開1.33
- 成交量 56.88万股
- 最 低 1.305
- 昨 收 1.36
- 總市值 1.32亿
- 52周最高 5.675
- 市盈率 靜 7.28
- 換手率 0.00%
- 52周最低 1.23
- 委 比 55.57%
- 總股本 9910.43万
- 歷史最高 11.41
- 量 比 1.20
- 振 幅 5.51%
- 歷史最低 1.23
- 每 手 1
- 風險率 0.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SEC Halts Grayscale’s GDLC ETF — But Analysts Still See 90% Chance for Altcoin ETF Approvals
On July 3, the U.S. Securities and Exchange Commission (SEC) unexpectedly paused the conversion of Grayscale’s Digital Large Cap Fund (GDLC) into a spot ETF, announcing a formal review just one day after initially approving the move.
07-03 07:04
DocGo Inc.'s (NASDAQ:DCGO) Shares Bounce 27% But Its Business Still Trails The Industry
DocGo公司（纳斯达克：DCGO）的股东无疑会高兴看到其股价在上个月上涨了27%，尽管它仍在努力弥补近期失去的地盘。并不是所有股东都会感到高兴，因为股价在过去...
06-20 18:27
美股大行评级 | 潜在涨幅455.56%！Medicus Pharma获D. Boral Capital升目标价至27美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1128971739548127232.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• D. Boral Capital：维持Medicus Pharma(MDCX)"买入"评级，目标价从14美元升至27美元</p> <p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从
05-13 08:50
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
05-12 21:26
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
Needham Maintains Buy on DocGo, Lowers Price Target to $3
Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $4 to $3.
05-10 01:23
DocGo shares are trading lower after the company reported worse-than-expected Q1 financial results.
DocGo shares are trading lower after the company reported worse-than-expected Q...
05-09 04:39
DocGo Lowers FY2025 Sales Guidance from $410.00M-$450.00M to $300.00M-$330.00M
DocGo (NASDAQ:DCGO) lowers FY2025 sales outlook from $410.00 million-$450.00 million to $300.00 million-$330.00 million.
05-09 04:34
DocGo Q1 EPS $(0.09) Misses $(0.02) Estimate, Sales $96.03M Miss $104.25M Estimate
DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.02) by 350 percent. This is a 190 percent decrease over earnings of $0.10 per share from the same
05-09 04:33
